First Nebraska Trust Co Acquires New Stake in Danaher Corporation $DHR

First Nebraska Trust Co acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 72,559 shares of the conglomerate’s stock, valued at approximately $16,075,000. Danaher comprises 1.3% of First Nebraska Trust Co’s portfolio, making the stock its 18th largest holding.

A number of other hedge funds also recently added to or reduced their stakes in DHR. Prime Capital Investment Advisors LLC raised its stake in shares of Danaher by 0.5% during the third quarter. Prime Capital Investment Advisors LLC now owns 9,203 shares of the conglomerate’s stock worth $2,039,000 after purchasing an additional 45 shares during the last quarter. Essential Investment Partners LLC lifted its holdings in shares of Danaher by 34.6% during the third quarter. Essential Investment Partners LLC now owns 175 shares of the conglomerate’s stock worth $39,000 after purchasing an additional 45 shares during the period. Veery Capital LLC grew its position in Danaher by 3.1% in the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after buying an additional 48 shares during the last quarter. Studio Investment Management LLC grew its position in Danaher by 3.3% in the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock valued at $302,000 after buying an additional 51 shares during the last quarter. Finally, Meridian Financial Partners LLC increased its stake in Danaher by 1.2% in the 3rd quarter. Meridian Financial Partners LLC now owns 4,636 shares of the conglomerate’s stock valued at $1,073,000 after buying an additional 56 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of analyst reports. Stifel Nicolaus upped their price objective on shares of Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, October 22nd. DZ Bank downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. JPMorgan Chase & Co. boosted their price target on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. Finally, UBS Group reissued a “buy” rating and set a $260.00 price target on shares of Danaher in a report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $242.91.

Insider Buying and Selling at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 10.80% of the stock is currently owned by company insiders.

Danaher Stock Up 0.9%

Danaher stock opened at $229.99 on Wednesday. The stock’s 50 day moving average price is $219.38 and its 200 day moving average price is $201.70. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market cap of $161.80 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.86 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. Danaher’s revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.89 earnings per share. On average, sell-side analysts predict that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is presently 26.19%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.